Ravn
Senior Member (Voting Rights)
The Conversation: AI will soon be able to audit all published research – what will that mean for public trust in science?
Probably very little because even if AI was perfect, the editors would still be in charge.The Conversation: AI will soon be able to audit all published research – what will that mean for public trust in science?
Given how much incompetence, bias and corruption it will expose, if anything it will show the necessity of moving away from human gatekeepers, with all their biases, friends in high places and how cheap humans are to buy.Probably very little because even if AI was perfect, the editors would still be in charge.
If they can do this with reasonable accuracy it sounds promising. The metadata could be interesting and scale of the project sounds interesting. They seem to be focusing on relationships between papers/embeddings, but I’m unsure if this would translate into tje granularity of some of the concepts we’d be interested in looking at.Project OSSAS is a large-scale open-science initiative to make the world’s scientific knowledge accessible through structured, AI-generated summaries of research papers
Details: Glycolytic enzyme expression is unchanged at the protein level in ME/CFS lymphoblasts, while PPP enzymes are upregulated (mean +20 ± 9%; p = 0.034) with G6PD elevated by 43 ± 10% (p = 5.5 × 10^−4).
Supporting Evidence: Figure 3B shows no significant differences in glycolytic enzyme levels (16 enzymes; binomial and t-tests non-significant). Figure 4A shows PPP enzymes upregulated (mean +20 ± 9%; t-test p = 0.034). Figure 4C shows G6PD elevated (p = 5.5 × 10^−4).
Implications: Supports a shift away from glycolysis toward PPP to supply TCA cycle substrates and NADPH, consistent with compensating for inefficient ATP synthesis.
Details: Plasma levels of TGF-β1, TGF-β2, and TGF-β3 are not elevated in adolescents with CFS compared to healthy controls.
Supporting Evidence: Independent sample comparisons showed no differences across all three isoforms (Table 2; Additional file 2: Table S1). Subgroup analyses by Fukuda and Canada 2003 criteria also showed no differences.
Implications: Systemic TGF-β levels are unlikely to serve as a biomarker distinguishing adolescent CFS from healthy controls; focus should shift to neuroendocrine–immune coupling mechanisms.